Skip to content

BD Phoenix Automated Microbiology System - Ciprofloxacin GN

by Becton, Dickinson & CO

510(k) K052269

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK052269 Date3 Oct 2005ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LON
Device Class
Class II
Regulation
21 CFR Part 866.1645
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BD Phoenix Automated Microbiology System - Ciprofloxacin GN is an automated system for in vitro rapid identification and quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration. It is designed for use with clinically significant aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria.

The system is supplied as a test system for use in clinical microbiology laboratories. It is intended for in vitro diagnostic use and has received FDA 510(k) clearance under product code LON and regulation number 866.1645. The device is classified as a Class II medical device.

Other devices from Becton, Dickinson & Co.

See all devices from Becton, Dickinson & Co. →

Questions

AI-generated answers, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the BD Phoenix Automated Microbiology System - Ciprofloxacin GN used for?

    It is used for in vitro rapid identification and quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) for clinically significant aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria in clinical microbiology laboratories.

  • How is the BD Phoenix Automated Microbiology System - Ciprofloxacin GN supplied?

    It is supplied as a test system for use in clinical microbiology laboratories and is intended for in vitro diagnostic use.

  • What regulatory clearance does the BD Phoenix Automated Microbiology System - Ciprofloxacin GN have?

    It has received FDA 510(k) clearance under product code LON and regulation number 866.1645, and is classified as a Class II medical device.